1. Home
  2. SFNC vs VRDN Comparison

SFNC vs VRDN Comparison

Compare SFNC & VRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Simmons First National Corporation

SFNC

Simmons First National Corporation

HOLD

Current Price

$20.53

Market Cap

2.7B

Sector

Finance

ML Signal

HOLD

Logo Viridian Therapeutics Inc.

VRDN

Viridian Therapeutics Inc.

HOLD

Current Price

$14.84

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SFNC
VRDN
Founded
1903
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.7B
IPO Year
1999
2014

Fundamental Metrics

Financial Performance
Metric
SFNC
VRDN
Price
$20.53
$14.84
Analyst Decision
Buy
Strong Buy
Analyst Count
6
14
Target Price
$22.50
$36.00
AVG Volume (30 Days)
1.3M
3.1M
Earning Date
04-16-2026
05-05-2026
Dividend Yield
4.05%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$5,706,000.00
Revenue This Year
$2,599.89
$28.34
Revenue Next Year
$3.96
$235.57
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.00
$11.76
52 Week High
$22.18
$34.29

Technical Indicators

Market Signals
Indicator
SFNC
VRDN
Relative Strength Index (RSI) 61.00 24.11
Support Level $18.38 $14.76
Resistance Level $20.77 $18.57
Average True Range (ATR) 0.46 1.39
MACD 0.23 -0.94
Stochastic Oscillator 70.68 10.29

Price Performance

Historical Comparison
SFNC
VRDN

About SFNC Simmons First National Corporation

Simmons First National Corp is a financial holding company. The company through its subsidiaries is engaged in providing banking services including consumer, real estate and commercial loans, checking, savings and time deposits. Its loan portfolio comprises construction, single-family residential and commercial loans; non-real estate loans, nonaccrual and past due loans; and credit card loans, student loans and other consumer loans. It also offers various products and services such as trust services, investments, agricultural finance lending, equipment lending, insurance, consumer finance and small business administration lending. The business activity of the firm is functioned through the region of the United States.

About VRDN Viridian Therapeutics Inc.

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).

Share on Social Networks: